COVID-19 may cause deadly blood clots
(The Endocrine Society) COVID-19 may increase the risk of blot cots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.
[New Zimbabwe] ATLEAST 415 school going girls dropped out of exam classes in Manicaland province during the Covid-19 lockdown period mainly due to marriage and pregnancy.
ConclusionA high cesarean delivery rate was found in uninfected women who experienced lockdown in their third trimester. During the COVID-19 pandemic, more medical support should be provided in severely affected regions to ensure and promote health in pregnancy.
After being epidemic in China, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) infection has rapidly spread in many countries as a global pandemic, with the number of affected cases dramatically increasing worldwide on a daily basis. Although the median age of hospitalized patients with confirmed infection is usually more advanced 1, with older age reported to be associated to higher mortality rate 2, physiological adaptations occurring during pregnancy have been claimed to be potentially responsible for a more severe respiratory disease, thus leading to higher rates of maternal and fetal complications 3,4.
The median length of symptoms was 37 days.
Publication date: Available online 9 October 2020Source: The Annals of Thoracic SurgeryAuthor(s): Sharon Beth Larson, Sarah N. Watson, Michael Eberlein, Jonathan S. Simmons, Kevin C. Doerschug, Kimberly K. Leslie
Condition: COVID-19 Intervention: Drug: Remdesivir Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group Not yet recruiting
The objective of this study was to determine the rate of abnormal serum cardiac biomarkers or bradycardia among pregnant and immediately postpartum women admitted for treatment of severe or critical COVID-19 in a large integrated health system in New York.
AbstractObjectivesWe investigate the effects of Ginger, compared to the usual therapeutic regimen on clinical manifestations and paraclinical features in patients with confirmed COVID-19 that are moderately ill.Trial designThis is a single center, randomized, double-blind, placebo-controlled clinical trial with parallel group design.ParticipantsInclusion criteria:1. Patients admitted to Severe Acute Respiratory Syndrome (SARS) Departments at Shahid Mohammadi Hospital, Bandar Abbas, Iran2. Age ≥18 years (weight ≥35 kg)3. Hospitalized ≤48 hours4. Confirmed SARS-CoV-2 diagnosis (Positive polymerase chain reaction (PC...
Most prevalent first symptoms cough, sore throat, body aches, fever for those testing positive for SARS - CoV - 2
[Global Sisters Report] Machakos -- Sarah, who is four months pregnant, ponders her fate as she sits in front of her house - watching her peers play outside their homestead in this settlement located 39 miles southeast of the capital, Nairobi. With her kanga wrapper tied around her bust and another colorful one on her waist, Sarah says she will not be returning to school even when coronavirus restrictions are eased.